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Abstract. Screening of a bacteriophage kgt 11 cDNA 
expression library with a polyclonal anti-microtubule 
associated protein (MAP) antiserum resulted in the 
isolation of two non-cross-hybridizing sets of cDNA 
clones. One set was shown to encode MAP2 (Lewis, S. 
A., A. Villasante, P. Sherline, and N. J. Cowan,  1986, 
J. Cell Biol., 102:2098-2105). To determine the speci- 
ficity of the second set, three non-overlapping frag- 
ments cloned from the same mRNA molecule via a 
series of "walking" experiments were separately sub- 
cloned into inducible plasmid expression vectors in 
the appropriate orientation and reading frame. Upon 
induction and analysis by immunoblotting, two of the 
fusion proteins synthesized were shown to be immu- 
noreactive with an anti-MAP 1-specific antibody, but 
not with an anti-MAP2-specific antibody. Since these 
MAP 1-specific epitopes are encoded in non-overlap- 
ping cDNAs cloned from a single contiguous mRNA, 
these clones cannot encode polypeptides that contain 
adventitiously cross-reactive epitopes. Furthermore, 
these cDNA clones detected an abundant mRNA spe- 
cies of >10 kb in mouse brain, consistent with the 
coding requirement of a 350,000-D polypeptide and 
the known abundance of MAP I in that tissue. 
The MAP l-specific cDNA probes were used in blot 
transfer experiments with RNA prepared from brain, 
liver, kidney, stomach, spleen, and thymus. While de- 
tectable quantities of MAP l-specific mRNA were ob- 
served in these tissues, the level of MAPI expression 
was -500-fold lower than in brain. The levels of both 
MAP l-specific and MAP2-specific mRNAs decline in 
the postnatal developing brain; the level of MAP l- 
specific mRNA also increases slightly in rat PC 12 cells 
upon exposure to nerve growth factor. These surpris- 
ing results contrast sharply with reported dramatic de- 
velopmental increases in the amount of MAP 1 in 
brain and in nerve growth factor-induced PC 12 cells. 
The cDNA clones encoding MAP I detect a single 
copy sequence in mouse DNA, even under conditions 
of low stringency that would allow the detection of 
related but mismatched sequences. The cDNAs cross- 
hybridize with genomic sequences in rat, human, and 
chicken DNA, but not with DNA from frog, Drosoph- 
ila, or sea urchin. These data are discussed in terms of 
the evolution and possible biological role of MAP1. 
T 
HE principal  components of all microtubules  are the 
a- and ~-tubulins. When these proteins are purified by 
co-polymerization  into microtubules in vitro, a num- 
ber of additional  polypeptides,  defined  as the  microtubule 
associated proteins  (MAPs), j consistently  co-purify through 
multiple  cycles of polymerization  and depolymerization  (9, 
29). Two groups of high molecular weight MAP, MAP1 and 
MAP2, are evident in microtubule preparations  from mam- 
malian brain, both of which stimulate  microtubule polymer- 
ization  in  vitro  (18,  24,  29). lmmunocytochemical studies 
have localized these proteins on the surface of  the microtubule 
polymer,  where  they appear in the electron  microscope  as 
1.  Abbreviations  used  in  this paper."  MAP,  microtubule  associated  protein; 
NGF, nerve growth factor; SSC, 150 mM NaCI, 15 mM Na citrate. 
protuberant  structures  that  could potentially  act  as cross- 
linking fibers in the cytoskeletal matrix (2, 7,  11,  12, 18, 21, 
24, 28, 31, 32). However, the role of MAP in vivo remains 
uncertain. 
Both MAP1 and MAP2 can be resolved into closely mi-  - 
grating bands of similar molecular weight on low percentage 
SDS polyacrylamide gels (6, 17). MAP2 consists of two sub- 
components,  MAP2a and MAP2b, both transcribed  from a 
single gene that is expressed exclusively in brain (23). MAP1, 
on the other hand, typically consists of three resolvable poly- 
peptides,  MAPIa,  MAPIb,  and  MAPlc.  The  relationship 
between these latter  molecules is unclear.  Whereas peptide 
mapping  data  suggests some relatedness  in  structure  (17), 
there  seem to be some significant immunological  and bio- 
chemical  differences (3, 6), and the genetic basis of MAP1 
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of MAP 1 polypeptides in vivo is a matter of controversy, with 
conflicting reports of these proteins either in a wide variety of 
non-neuronal cell types (7,  33),  or exclusively in neurons of 
the  adult  brain,  where  they  are  predominantly  present  in 
dendrites (5,  19, 20). 
The isolation of  cloned cDNAs encoding the high molecular 
weight MAP would serve to define the genetic basis of MAP 
heterogeneity, as well as provide approaches to defining their 
structure and function. Such cloned probes should also allow 
the  determination  of  patterns  of  cell-  and  tissue-specific 
expression based on the detection of mRNA sequences (rather 
than epitopes), and can be used to define evolutionary rela- 
tionships among MAP polypeptides in  different species. In 
the accompanying paper, we describe the isolation of cDNA 
clones encoding  MAP2,  and  show that the expression of a 
single MAP2 gene is restricted exclusively to brain. Here we 
describe the isolation of a  set of overlapping cloned cDNAs 
encoding  MAP1.  These  probes  detect  a  single  gene,  with 
preponderant (though not exclusive) expression in brain. The 
probes  have  also  been  used  to  monitor the  expression  of 
MAPI  mRNA in PCI2 cells,  where there is a reported dra- 
matic increase in the synthesis of MAPI protein in response 
to induction of differentiation by nerve growth factor (NGF) 
(13,  14, 16). However, the data reveal only a minor elevation 
in the abundance of MAP 1-specific mRNA under these con- 
ditions. 
Materials and Methods 
Construction and screening of a mouse brain cDNA expression library, exten- 
sion of clones by "walking," DNA and RNA blot transfer procedures, and the 
generation and characterization of mouse anti-MAPl and anti-MAP2-specific 
antisera are described in the accompanying paper (23). RNA was prepared by 
the guanidine  isothiocyanate procedure  (4) from mouse tissues or from  rat 
PCI2 cells (15) (generously provided by Lloyd Greene) exposed for varying 
times to NGF. 
Results 
Stratagem for the Identification of  cDNA Clones 
Encoding MAPl from a ~gtl l  Expression Library 
Using a MAP-specific Antiserum 
The construction and screening of a Xgtl I cDNA expression 
library using a MAP-specific rabbit anti-rat MAP antiserum 
(28)  is described in the accompanying paper (23).  This anti- 
serum was chosen because it detects both MAPI and MAP2, 
and therefore offered the potential of simultaneously detecting 
fusion proteins in the  ~, library that contained epitopes for 
either MAP1  or MAP2. This approach proved successful, in 
that two sets of cross-hybridizing clones were obtained, with 
no  detectable  cross-hybridization  between  each  set.  Upon 
further analysis, one set of clones proved to encode MAP2 
(23).  A  number of experiments were done to  establish the 
identity of the second set of overlapping clones. As in the case 
of MAP2,  attempts  to  establish  the  nature  of the  protein 
encoded  by  these  clones  by  hybrid  selection  (using  brain 
mRNA)  and  translation  of selected  material  in  a  cell-free 
system yielded a spectrum of immunoprecipitable translation 
products  of <200,000  D  that  could  not  be  characterized 
further (data not shown). Furthermore, while the set of Xgt I 1 
cDNA clones encoding MAP2 fusion proteins gave a conspic- 
uously positive signal upon  assay with the anti-MAP  anti- 
serum, the signal from the second set of cDNA clones was 
considerably weaker relative to the background (Fig.  1). The 
significant background signal could not be the result of con- 
taminating  anti-E,  coli antibodies  in  the  anti-MAP  anti- 
serum,  since the  latter was affinity purified  (28):  rather,  it 
appears likely that MAP proteins contain one or more epi- 
topes in common with E. coli antigens. This interpretation is 
consistent with our observation that absorption of  the affinity- 
purified anti-MAP antiserum against a  crude E. coli lysate 
resulted in a  reduction in intensity of both signal and back- 
ground (data not shown). Therefore, for the clones expressing 
weakly immunoreactive fusion proteins, it was not possible 
to use the fusion proteins expressed by the originally isolated 
clones  to  select  antibodies  for  the  determination  of their 
specificity by immunoblotting.  As  an  alternative,  we  used 
anti-MAPl and anti-MAP2 specific antisera (23) as a means 
to distinguish between clones encoding these two proteins. 
At Least Two MAPl-specific Epitopes Are Encoded by 
Non-overlapping  Cloned cDNAs 
Fragments derived from the ends of the cloned cDNAs de- 
tected in the Xgt 11 expression library as expressing weak but 
nevertheless positively immunoreactive fusion proteins (Fig. 
1  B) were used as labeled DNA probes to rescreen the library 
so as to obtain extended overlapping cloned fragments. To 
exclude the possibility that such overlapping fragments might 
contain cloning artifacts, multiple isolates were examined by 
restriction mapping for the presence of common restriction 
sites within the region of overlap. Restriction maps of the set 
of overlapping clones obtained in this manner are shown in 
Fig.  2.  Three cloned EcoRI fragments (clones A, B, and D, 
Fig.  2)  were  each  inserted  in  both  orientations  into  three 
plasmid vectors (Koerner, T.  J.,  Duke University, personal 
communication;  see  also  [23])  designed  to  express  cloned 
Figure 1.  Detection of cDNA-encoded fusion proteins expressed in 
bacteriophage ~gtl I using an anti-MAP antiserum. A cDNA expres- 
sion library was  constructed in bacteriophage  ~,gtl 1 using polyA  ÷ 
mRNA  from  8-d-old  mouse  brain.  About  5  x  105  plaques  were 
screened using a  rabbit anti-rat  MAP  antibody that detects  both 
mouse MAPI  and mouse MAP2 (28).  Seven clones were detected 
that were immunoreactive with the antiserum: three yielded a strong 
signal that proved to be due to MAP2 epitopes (23); the remaining 
four yielded weaker signals with the anti-MAP antibody. Examples 
of the immunoreactivity of one member of each class are shown at 
the penultimate purification step against a  background of negative 
clones. (A) Strongly immunoreactive; (B) weakly immunoreactive. 
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Figure 2. Characterization of  a series of  overlapping cDNAs encoding 
the same contiguous  mRNA molecule.  Several overlapping eDNA 
clones were isolated by rescreening the Xgt 11 eDNA library with the 
insert excised from the longest member of  the set of  clones expressing 
a weakly immunoreactive  MAP fusion protein (E). Extended regions 
of cloned eDNA were then used in further screening experiments to 
produce the collection of cloned fragments shown in the figure. The 
transcriptional  orientation  (arrowed) was established by restriction 
mapping of the original expression clone in hgt 11 with respect to the 
lac Z promoter. The vertical arrow indicates the approximate position 
of the translational termination codon, determined  from the size the 
fusion proteins expressed by clone 52 (data not shown) and fragment 
B. Fragments A. B, C, and D were subcloned and used for the purposes 
described in the text. ~r, Sacl; e, Pstl; O, Kpnl; V, BgllI. Vertical 
bars denote EcoRl sites. 
inserts  as  fusion  proteins  transcribed  from  the  E.  coli trp 
promotor and translated in all six reading frames.  After in- 
duction with indole acrylic acid, the host cells were examined 
by SDS PAGE and immunoblotting for the presence of fusion 
proteins that were immunoreactive with the anti-MAP anti- 
serum  used  to detect  the  original  expression  clones  in  the 
~gt 11  library. The result of this experiment is shown in Fig. 
31: in  only one frame and orientation,  cloned fragments B 
and D (Fig. 2) yielded fusion proteins of 48,000 D and 55,000 
D, respectively, that were strongly immunoreactive with anti- 
MAP antibody. Since clone B and clone D are derived from 
the same mRNA species, this experiment demonstrates that 
a minimum of two MAP epitopes are recognized on the same 
molecule by our anti-MAP antiserum.  Clone A  yielded no 
immunoreactive fusion protein in any orientation. This result 
was expected,  because based on the size of our MAP1  im- 
munoreactive fusion proteins, and the direction of transcrip- 
tion of these expressing clones, we predicted that fragment A 
would represent entirely 3' untranslated region (see legend to 
Fig. 2). 
To show that the immunoreactive fusion proteins expressed 
by clone B and clone D (Fig. 2) contained epitopes present in 
MAP 1, but not MAP2, an immunoblot experiment was done 
using MAP 1- and MAP2-specific antisera (23). The data (Fig. 
3 II) show that the fusion proteins encoded by both clone B 
and  clone  D  are  detected  by the  anti-MAP 1-specific anti- 
serum,  but  not the anti-MAP2  antiserum.  On the basis of 
this evidence, the detection of multiple overlapping clones in 
the ~,gt  I 1 expression library, and the size and tissue distribu- 
tion of the mRNA detected by the clones depicted in Fig. 2 
(see below), we conclude that these sequences encode mouse 
MAP1. 
Size and Tissue Distribution of  MAP1 mRNA 
The size and heterogeneity (if any) of the mRNA detected by 
our cloned cDNAs were determined in an RNA blot transfer 
experiment  in  which  total  8-d-old  mouse  brain  RNA was 
probed with the excised inserts from subclones B-D (Fig. 2) 
32p-labeled  by nick-translation  (26).  A  single band was ob- 
served (Fig. 4A) that showed some evidence of degradation. 
This pattern, which was reproducibly observed irrespective of 
the developmental age or method of preparation of the RNA, 
is probably a reflection of degradation in vivo, since neither 
MAP2  mRNA  (23),  neurofilament  mRNA,  glial  filament 
mRNA,  nor a- or fl-tubulin  mRNAs detected  in  the same 
preparations showed any appreciable evidence of degradation 
(data  not  shown).  In the  absence  of good high  molecular 
weight  RNA markers,  the exact  size of the  MAP1  mRNA 
species  was  impossible  to  ascertain.  The  use  of DNA  size 
markers showed them to be essentially unresolved in the high 
molecular weight  range  on  denaturing  gels that  contained 
formaldehyde, and in any case, they failed to run true with 
respect to ribosomal RNAs. On the basis of the migration of 
the MAP1 mRNA species relative to these imperfect markers, 
we estimate that the size of MAP1 mRNA is >10 kb. 
Previous  studies  using  fluorescent  MAPl-specific  poly- 
clonal and monoclonal antisera have detected MAP1 protein 
both as an abundantly expressed  protein in brain (5,  6,  19, 
20) and also in a variety of non-neuronal tissues and cell lines 
(7,  33).  Such non-neuronal expression of MAP1  might have 
been observed as a  consequence of cross-reactivity between 
epitopes present in non-MAP 1 proteins. To detect the expres- 
sion  of MAP-1  at  the  mRNA  level,  an  RNA blot transfer 
experiment was done in which total RNA from mouse brain, 
kidney, liver, stomach, spleen, and thymus was probed with 
our MAP 1-specific cDNA probes.  The data show abundant 
expression of the MAPl-specific mRNA in brain, with very 
much lower but nonetheless detectable levels in all the other 
tissues examined (Fig. 4 B). 
Regulation of MAP1 and MAP2 mRNAs in the 
Developing Mouse Brain and of  MAP1 mRNA in Rat 
PC12 Cells in Response to NGF 
Previous  studies  using  immunoblot  analysis  have  revealed 
measurable changes in the levels of MAP1 and MAP2 in brain 
as a function of  development. In particular, a marked increase 
in  the  abundance  of MAPI  with  increasing  age  has  been 
reported (25). To see whether these changes were reflected at 
the mRNA level, total mRNA was prepared from the brains 
of mice of varying age and analyzed in an RNA blot transfer 
experiment using MAP 1- and MAP2-speeific cloned probes. 
a- and fl-Tubulin probes (10) were included in this experiment 
for  comparison  of developmental  expression  and  relative 
abundance.  Surprisingly, the result shows that both MAP1- 
and MAP2-specific mRNA decline somewhat from birth, the 
decline being much more pronounced in the case of MAPI 
(Fig. 5). 
Rat PC 12 cells have been widely used as a model system of 
neuronal differentiation (15).  Recently, two groups (14,  16) 
have reported a dramatic (10-20-fold) increase in the expres- 
sion  of MAP1  in  these  cells  upon  stimulation  with  NGF 
The Journal of Cell Biology, Volume 102, 1986  2108 Figure 3. Two fusion proteins expressed by non-overlapping cDNAs encoding a contiguous mRNA each contain at least one MAPl-specific 
epitope. (I) EcoRI fragments A, B, and D (Fig. 2) were subcloned into inducible plasmid expression vectors (see text) in all six potential reading 
frames (lanes 1-6). The fusion proteins encoded by these constructs were then analyzed by immunoblotting of total E. coli lysates using in 
each case the anti-rat MAP antibody used to screen the hgtl 1 expression library (28). (H) Two pairs of clones (from panel L B5 and B6, D3 
and D4) each pair containing inserts in opposite orientation and expressing an irnmunoreactive fusion protein in one of these orientations, 
were further analyzed along with an equivalent pair of MAP2 expression  clones (23) as a control (tracks E1 and E2). (1) Coomassie Blue- 
stained gel of E. coli lysates. (2-4) Immunoblots of duplicate gels stained with (2) the anti-rat MAP antibody (which recognizes both MAPI 
and MAP2) used to screen the expression library (28), (3) the anti-mouse MAPl-specific  antibody (23), and (4) the anti-mouse MAP2-specific 
antibody (23).  Irnmunoreactive fusion  proteins are  arrowed.  M,  molecular size  markers (in  kilodaitons). The  high  molecular weight, 
immunoreactive species uniquely present in track I1.3.D4 is ascribable to a fusion protein encoded by fragment D, which mutated in the host 
bacteria expressing this fragment to give the shorter and more abundant fusion protein evident in the same track. 
concomitant  with  the  characteristic outgrowth  of neurites. 
This increase was reversed when NGF was removed and the 
neurites  disappeared.  Because  the  mouse  MAPl-specific 
probes described here cross-hybridize with corresponding se- 
quences in rat (see below), we were able to test whether these 
reported NGF-induced alterations in the level of MAP1  pro- 
tein in rat PC12 cells were accompanied by an increase in the 
abundance  of MAPl-specific mRNA.  Total  RNA was  pre- 
pared from PC I2 cells at various times after their exposure to 
NGF.  The result (Fig. 6) shows only a  moderate change in 
the level of MAPl-specific sequences; MAP2 is undetectable 
in these cells, 
Clones B,  C, and D  Detect a  Single Gene in Mouse 
To determine the number of genomic sequences homologous 
to our MAPl-specific probes, a genomic Southern blot exper- 
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completion with either BamHI or Kpn 1. These enzymes were 
chosen  for  this  experiment  because  the  non-overlapping 
cloned fragments B,  C, and D  (Fig. 2) encoding MAPI  lack 
recognition sites for these enzymes. The blot was hybridized 
and washed under low stringency conditions (Fig. 7), so as to 
allow the potential detection of mismatched sequences bear- 
ing some homology to the cDNA probes in addition to the 
homologous genomic sequences. The result shows that, irre- 
spective of the final stringency conditions, the non-overlap- 
Figure 5. Changes in the level 
of MAP1  and  MAP2-specific 
mRNAs  in  the  developing 
mouse brain.  Aliquots (10 #g) 
of total  RNA  prepared  from 
the brains  of mice of varying 
ages were  resolved  on  0.8% 
agarose gels that contained  1.5 
M formaldehyde (8) and the gel 
content transferred to nitrocel- 
lulose  (30). The  blots  were 
prehybridized  and  hybridized 
with the ~2P-labeled excised in- 
serts from (A) MAPl-specific 
cloned cDNAs; (B) MAP2-spe- 
cific cloned cDNAs (23); (C) a 
chicken a-tubulin eDNA (10); 
(D) a chicken #-tubulin eDNA. 
After  hybridization,  the  blots 
were washed  to a  final  strin- 
gency of 2 x  SSC, 68"C. Post- 
natal ages of mice used for the 
preparation  of RNA are shown 
above each track. 
Figure 4. A single mRNA encod- 
ing mouse MAP1 and  its tissue- 
specific  expression.  Aliquots  of 
RNA prepared from mouse tissues 
were resolved on an 0.8% denatur- 
ing  agarose  gel  (8), and  the  gel 
content transferred  to nitrocellu- 
lose (30). (A) RNA (10 #g) from 
15-d-old mouse brain probed with 
the excised insert  from clone  52 
(Fig. 2)  and a  chicken  fl-tubulin 
eDNA  (10) 32p-labeled by  nick- 
translation (26). fl, 2.2-kb and 1.8- 
kb/~.tubulin  mRNAs. (B and C) 
PolyA  + mRNA 05 #g) from 32-d- 
old  mouse  brain,  kidney,  liver, 
spleen,  stomach,  and  thymus 
probed  as  in A,  but  without  the 
chicken B-tubulin eDNA. (B)  12- 
h  exposure;  (C)  20-d  exposure 
(both with an intensifying screen). 
After hybridization  in 50%  form- 
amide, 5 x  SSC, 42"C, blots were 
washed to a final stringency of 2 x 
SSC, 68"C. 
ping cloned cDNAs B,  C, and D  detect a  single  restriction 
fragment in either digest (Fig. 7); clone A, which consists of 
3' untranslated region sequences (Fig. 2), detects a continuum 
of hybridizing  fragments  consistent  with  hybridization  to 
repetitive sequences (data  not shown).  These data therefore 
demonstrate the existence of a single mouse gene correspond- 
ing to clones B, C, and D, that is not a member ofa multigene 
family related by detectable homology at the DNA level. 
Sequences Encoding Mouse MAP1 Cross-hybridize 
with Sequences in Rat, Human, and Chicken DNA, 
But Not with DNA from Frog, Drosophila,  or 
Sea Urchin 
The ability of anti-MAP 1 antisera to detect epitopes across 
species boundaries (7,  33) implies the interspecies conserva- 
tion of  at least some MAP 1-specific sequences. However, these 
experiments do not provide a measure of the extent of inter- 
species conservation, and, in any case, the possibility of inter- 
species cross-reactivity of related epitopes on non-MAPl pro- 
teins cannot be ruled out. To investigate interspecies homol- 
ogies at the DNA level,  a genomic Southern blot experiment 
was done using DNA from mouse, rat, human, chicken, frog, 
sea urchin, and Drosophila (lanes I-7). The data show that, 
under conditions of low stringency, the mouse MAPI probe 
detects two bands in  rat,  and a  single band  in  human  and 
chicken DNA, but not in the genomes of the other species 
examined (Fig. 8).  The cross-reactivity with rat and human, 
but  not  with  chicken  DNA,  remained  when  the  blot  was 
rewashed to high stringency (0.2  x  150 mM NaC1,  15 mM 
Na citrate  [SSC], 68"C) (data not shown).  The background 
hybridization evident in frog and sea urchin DNA at 2 x  SSC, 
42"C (lanes 5  and 6) also disappeared  at higher stringency. 
Thus, while there seems to be considerable conservation of 
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MAPl-specific mRNA in NGF-in- 
duced PC i 2 cells. (A) Aliquots ( 10 
#g) of RNA from rat brain (lanes 
I  and  4)  and  from  PC12  ceils 
either unexposed (lanes 2  and 5) 
or exposed for 10 d (lanes 3 and 6) 
to NGF were resolved on a  0.8% 
agarose gel that  contained  1.5  M 
formaldehyde (8) and the gel con- 
tent  transferred  to  nitrocellulose 
(31).  The  blots  were  hybridized 
with either the excised 32p-labeled 
insert  from  clone  56  (encoding 
MAP2,  reference 23)  (lanes  1-3) 
or with the 32p-labeled insert from 
clone 52 (encoding MAPI, Fig. 2) 
(lanes  4-6).  In  each  case,  the 
probes  were  mixed with  the  32p_ 
labeled  insert  from  a  chicken  /3- 
tubulin eDNA (10)  to provide in- 
ternal size markers and as a check 
on  the  integrity  of  the  mRNA 
preparations. (B) Aliquots (10 #g) 
of total RNA from PC 12 cells ex- 
posed to NGF for the times shown 
in the figure were resolved in an 
0.8%  denaturing  agarose  gel  (8) 
and the gel content transferred to 
nitrocellulose (30).  The blot was prehybridized, and hybridized with the same probes used in A, lanes 4-6. All blots were washed to a  final 
stringency of 2 x  SSC, 45"C. #,  1.8-kb,  2.2-kb, and 2.6-kb/3-tubulin mRNAs. 
Figure  7.  MAP i-specific  cDNA 
clones detect a single copy gene in 
mouse.  Aliquots (5  #g) of mouse 
genomic DNA were digested with 
BamHI  (left hand  lanes) or KpnI 
(right hand  lanes),  resolved on  a 
0.8% agarose gel, and the gel con- 
tent  transferred  to  nitrocellulose 
(30).  Separate  blots  were  probed 
with  MAP1  cDNA  fragments  B, 
C,  and  D  (Fig.  2)  32P-labeled  by 
nick-translation (26).  So as to al- 
low the detection of possible ho- 
mologous  but  mismatched  se- 
quences in the genomic DNA, the 
blots  were  hybridized  (in  40% 
formamide,  5  x  SSC,  42"C)  and 
were initially washed to low strin- 
gency (2  x  SSC, 42"C) (panel I), 
and then to high stringency (0.2  x 
SSC,  68"C) (panel H). An intense 
continuum  of  labeling  was  de- 
tected by fragment A (Fig. 2) which 
remained  after  washing  to  high 
stringency (data not shown). 
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(5 #g) of genomic DNAs were digested with HindlII, the fragments 
resolved  on a 0.8%  agarose gel, and the gel content transferred to 
nitrocellulose  (30). The blot was prehybridized and hybridized  with 
the mixed probes B, C, and D and washed as described in the legend 
to Fig. 7, panel L Lanes 1-7, DNA from mouse, rat, human, chicken, 
frog, sea urchin,  and Drosophila. Molecular size markers (in kb) are 
shown at the left. 
MAP1  genomic  sequences  within  mammalian  species,  this 
conservation does not extend to invertebrate species. 
Discussion 
In the accompanying paper (23), we describe the isolation of 
a series of overlapping cloned cDNAs encoding mouse MAP2. 
These  clones  were  detected  as a  result  of the  expression  of 
immunoreactive fusion proteins in the host by bacteriophage 
~,gtl 1. Since the antiserum used in the screening experiments 
(28) detected both MAP1  and MAP2 (23), the detection of a 
second  set  of clones  that  did  not  cross-hybridize  with  the 
MAP2-specific cDNAs but that nonetheless expressed weakly 
immunoreactive fusion proteins (Fig.  1 B), suggested the pos- 
sibility that they might encode mouse MAP1. To explore this 
possibility,  a  number  of experimental  approaches were  un- 
dertaken.  First, a  series of cDNA "walking" experiments was 
done that served both to extend the region of cloned DNA, 
as well as provide cloned fragments that were contiguous but 
non-overlapping with  respect to the  original  cloned  cDNA. 
Expression of these non-overlapping cloned fragments in an 
inducible  plasmid  vector  yielded  fusion  proteins  that  were 
immunoreactive  with  a  polyclonal anti-MAPl-specific  anti- 
body, but not with a polyclonal anti-MAP2-specific antibody 
(Fig. 3). Thus, that portion of the mRNA species represented 
by the series of overlapping cloned cDNAs shown  in  Fig.  2 
encodes  a  minimum  of two  MAPl-specific  epitopes.  The 
statistical  probability of detecting  a  single  polypeptide  con- 
raining  two  epitopes  both  adventitiously  recognized  by  a 
MAPl-specific antiserum is vanishingly small. We conclude, 
therefore,  that  the  series  of cDNA  clones  shown  in  Fig.  2 
encodes mouse MAP 1. This conclusion is consistent with the 
very large size of  the mRNA molecule detected by these eDNA 
probes, and its tissue distribution,  discussed below. 
The cDNA probes shown in Fig. 2 detect an mRNA species 
of >10  kb  in  mouse  brain.  The  mRNA  appears as  a  pro- 
nounced band together with a smear of hybridizing sequences 
of lower size.  This continuum  does not  seem likely to be a 
consequence of mRNA degradation during the isolation pro- 
cedure, since MAP2 mRNA (which is only slightly smaller in 
size)  is  largely  intact  in  the  same  RNA  preparations  (23). 
Rather,  it  appears  that  there  are  significant  quantities  of 
partially  degraded  MAPI  mRNA  in  vivo,  and  that  these 
molecules co-purify with intact mRNA. The large size of the 
mRNA detected by our cloned probes is consistent with the 
coding requirement for MAP 1: though the exact size of MAP 1 
polypeptides is uncertain,  an Mr of 350,000  would require a 
coding capacity of -9.5 kb. The approximate location of the 
stop codon is indicated in Fig. 2, as deduced from the size of 
the original ~,gtl 1 fusion proteins and their direction of tran- 
scription. Thus, about half of  the region covered by our cDNA 
clones corresponds  to coding  sequences,  and  half to  3'  un- 
translated region. 
Previous studies using MAP 1-specific antibodies have iden- 
tified  MAPl-cross-reactive  epitopes  in  several  tissues  other 
than brain (33) as well as in  a  wide variety of tissue culture 
cell  lines  (7,  33).  The  tissue  distribution  of MAPI  mRNA 
detected  by  our  cloned  cDNA  probes (Fig.  4)  is consistent 
with these observations, though the level of expression (rela- 
tive to that in brain) is exceedingly low. Indeed, it is conceiv- 
able that the very weak signals obtained in blots containing 
RNA from non-neuronal  tissues could in at least some cases 
be a result of MAP l-specific mRNA contained exclusively in 
innervating  cells  associated  with  that  tissue.  In  any  event, 
quantitative  comparison  of the  MAPl-specific  signals  de- 
tected in brain RNA with MAPl-specific signals detected in 
non-neuronal  tissue  shows that they differ by a  factor of at 
least 500, and the level of MAP1  expression in tissues other 
than brain is therefore exceedingly low. 
The  abundance  of  MAP1-  and  MAP2-specific  mRNAs 
declines slightly  in the developing  mouse brain,  the decline 
being much more pronounced in the case of MAPI  (Fig.  5). 
Moreover, there was only a slight change in the level of MAP i- 
specific mRNA in rat PC12 cells upon exposure to NGF (Fig. 
6). These results are rather surprising in view of the reported 
increase in the level of MAP1  that occurs in the developing 
postnatal  rat  brain  (5),  and  the  dramatic  rise  in  MAP1  in 
NGF-induced  rat  PC12  cells (14,  16).  Such  increases could 
be explained  by regulation  of MAP1  at the  translational  or 
posttranslational level. In this context, it is interesting to note 
that the microtubule associated proteins r  appear to be regu- 
lated in this fashion (13). To test this hypothesis, we measured 
changes in the level of MAP1  protein in PCI2 cells exposed 
to  NGF  in  an  immunoblotting  experiment  using the  poly- 
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contrast to the reported dramatic increase observed using an 
anti-MAP1 monoclonal antibody (14), we found little detect- 
able increase in MAPI  levels (data not shown). This discrep- 
ancy could be explained by differences in the epitopes recog- 
nized by the monoclonal and polyclonal antisera; for example, 
the  monoclonal antibody  could  be  specific  for an  epitope 
conferred on the protein by phosphorylation. 
On  low  percentage  SDS  polyacrylamide  gels,  MAP1  is 
resolvable  into  three  distinct  subcomponents,  MAPla, 
MAPIb, and MAPle (6, 7). While these polypeptides are to 
some extent immunologically and biochemically distinct, the 
genetic relationship between them is unclear. Genomic South- 
ern blot analysis using cloned cDNAs corresponding to the 
coding region of MAP1 detected a single restriction fragment 
in  digests  of mouse  DNA,  even  under  conditions  of low 
stringency (2 x  SSC, 42"C) (Fig. 7). Thus, the gene encoding 
MAP1  is  not a  member of a  multigene family,  at least as 
defined by the ability of family members to cross-hybridize at 
the DNA level. The single copy gene detected by the cDNAs 
characterized  in  this  work  could  encode  either  MAPla, 
MAPlb, or MAPlc, or, by a process of differential splicing of 
alternative exons, it could encode two or conceivably all three 
of these polypeptides. An alternative splicing mechanism has 
been shown to operate, for example, in the generation from a 
single gene of several related but distinct fibronectin (27) or 
calcitonin (1) polypeptides. In this context, it is interesting to 
note  that  one  of the  eDNA  expression  clones,  clone  37, 
isolated from )~gt  11 library (see Fig. 1 of accompanying paper) 
differs from others spanning the same region in that it lacks 
an EcoRI restriction site (Fig.  2). Experiments are currently 
directed towards establishing whether this restriction site dif- 
ference reflects a polymorphic variation. Alternatively, clone 
37  might  lack  this  site  because  it  lacks  DNA  sequences 
corresponding to an exon that is encoded by other overlapping 
clones. 
The  MAPl-specific  cDNA  clones  described  here  cross- 
hybridize under high stringency conditions (0.2 x  SSC, 68"C) 
with rat and human genomic DNA, but not with DNA from 
any other non-mammalian source tested  (Fig.  8).  Thus,  in 
contrast to a- and/~-tubulin,  both of which are extensively 
evolutionarily conserved (10), there would appear to be con- 
siderable species divergence in the sequences encoding MAP1. 
This could reflect either the absence of strong selective con- 
straints over the region of the protein encoded by our cDNAs, 
or some divergence of MAP1  function among different spe- 
cies.  A  similar  lack  of interspecies  sequence  conservation 
applies in the case of MAP2 (23). 
While  the  genetic  basis  of MAPI  heterogeneity and  the 
precise  biological  function of MAP1  remain uncertain, the 
isolation  of cloned  probes  provides  a  starting  point  for  a 
molecular and  functional  analysis  of these  proteins at  the 
nucleic acid level. In particular, it should be possible to use 
these  probes inserted  into appropriate  vectors (22)  for the 
extinction of MAP1  gene expression,  and to determine the 
effect of such targeted elimination of MAPI  on cell growth 
and neuronal differentiation. 
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